{"nct_id":"NCT04199689","title":"Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-03","start_date":"2020-02-27","start_date_type":"ACTUAL","primary_completion_date":"2027-08-27","primary_completion_date_type":"ESTIMATED","completion_date":"2028-08-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}